[1]
K. Khan, E. Murphy, and C. L. Murphy, “Eosinophilic fasciitis as an immune-related adverse event of Pembrolizumab in Hodgkin’s lymphoma: a case report”, Khyber Med Univ J, vol. 16, no. 2, pp. 171–4, Jun. 2024.